Patents by Inventor Somphet Peter Suphasawud

Somphet Peter Suphasawud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9844538
    Abstract: A method of alleviating or treating a condition which can be alleviated or treated by administering hyoscyamine comprises administering to a subject in need thereof a pharmaceutical dosage form which comprises at least one of hyoscyamine and a pharmaceutically acceptable salt thereof. The dosage form comprises two or more hyoscyamine formulations, at least one of the formulations being an immediate release formulation and at least one other one being a controlled release formulation.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: December 19, 2017
    Assignee: Sovereign Pharmaceuticals, LLC
    Inventors: Viswanathan Srinivasan, Ralph Brown, David Brown, Himanshu Patel, Juan Carlos Menendez, Somphet Peter Suphasawud
  • Patent number: 9592197
    Abstract: A pharmaceutical dosage form which comprises diphenhydramine and/or a pharmaceutically acceptable salt thereof and at least one second drug. The dosage form provides a plasma concentration within the therapeutic range of the at least one second drug over a period which is coextensive with a substantial part of the period over which the dosage form provides a plasma concentration within the therapeutic range of diphenhydramine or salt thereof. This Abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
    Type: Grant
    Filed: December 16, 2004
    Date of Patent: March 14, 2017
    Assignee: SOVEREIGN PHARMACEUTICALS, LLC
    Inventors: Viswanathan Srinivasan, Juan Carlos Menendez, Venkatesh Balasubramanian, Somphet Peter Suphasawud, Ralph Brown, David Brown
  • Patent number: 9492541
    Abstract: A pharmaceutical dosage form which comprises phenylepherine or a pharmaceutically acceptable salt thereof and a second drug. The dosage form provides a plasma concentration within the therapeutic range of the second drug over a period which is coextensive with at least about 70% of the period over which the dosage form provides a plasma concentration within the therapeutic range of phenylepherine. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
    Type: Grant
    Filed: September 14, 2004
    Date of Patent: November 15, 2016
    Assignee: SOVEREIGN PHARMACEUTICALS, LLC
    Inventors: Viswanathan Srinivasan, Ralph Brown, David Brown, Juan Carlos Menendez, Venkatesh Balasubramanian, Somphet Peter Suphasawud
  • Publication number: 20160213656
    Abstract: A method of alleviating or treating a condition which can be alleviated or treated by administering hyoscyamine comprises administering to a subject in need thereof a pharmaceutical dosage form which comprises at least one of hyoscyamine and a pharmaceutically acceptable salt thereof. The dosage form comprises two or more hyoscyamine formulations, at least one of the formulations being an immediate release formulation and at least one other one being a controlled release formulation.
    Type: Application
    Filed: April 1, 2016
    Publication date: July 28, 2016
    Inventors: Viswanathan SRINIVASAN, Ralph BROWN, David BROWN, Himanshu PATEL, Juan Carlos MENENDEZ, Somphet Peter SUPHASAWUD
  • Patent number: 9308164
    Abstract: A pharmaceutical dosage form which comprises two or more different hyoscyamine formulations, at least one of the formulations being an immediate release hyoscyamine formulation and at least one other one being a controlled release hyoscyamine formulation. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: April 12, 2016
    Assignee: Sovereign Pharmaceuticals, LLC
    Inventors: Viswanathan Srinivasan, Ralph Brown, David Brown, Himanshu Patel, Juan Carlos Menendez, Somphet Peter Suphasawud